Skip to main content
Top
Published in: Immunologic Research 5/2021

01-10-2021 | Bronchiectasis | Brief report

A novel ITGB2 variant with long survival in patients with leukocyte adhesion defect type-I

Authors: Mehmet Halil Celiksoy, Mustafa Yavuz Köker, Alper Gezdirici, Sevil Ozsoy, Baris Malbora, Songul Gungor

Published in: Immunologic Research | Issue 5/2021

Login to get access

Abstract

Leukocyte adhesion deficiency is an autosomal recessive primary immunodeficiency that has been divided into three types: LAD1 (beta-2 integrin (CD18) family deficiency/defect), LAD2 (absence of fucosylated carbonhydrate ligands for selectins) and LAD3 (defective activation of all beta integrins). However, recently LAD4 has been described in cystic fibrosis patients, with a defect in integrin activation reported in monocytes. LAD-I is the most common type and prevalence of 1 in 1,000,000 live births. Clinical features of LAD patients are recurrent bacterial and fungal infections, omphalitis with delayed umbilical stump separation, significant leukocytosis especially neutrophilia during infection periods, impaired pus formation, and delayed traumatic or surgical wound healing. Flow cytometry is considered a useful tool for rapid diagnosis of the disease. The study of CD18 and CD11 (a, b, c) expression patterns in peripheral blood leukocytes helps to distinguish different phenotypes of LAD-I. In general, patients with ≥ 2% CD18 expression tend to have a less severe infection and often survive until adulthood, whereas < 2% CD18 expression often results in death in infancy. In this case report, three siblings, 10, 15, and 17 years old, diagnosed with leukocyte adhesion defect type 1 in adolescence age group, are presented.
Literature
Metadata
Title
A novel ITGB2 variant with long survival in patients with leukocyte adhesion defect type-I
Authors
Mehmet Halil Celiksoy
Mustafa Yavuz Köker
Alper Gezdirici
Sevil Ozsoy
Baris Malbora
Songul Gungor
Publication date
01-10-2021
Publisher
Springer US
Published in
Immunologic Research / Issue 5/2021
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-021-09222-3

Other articles of this Issue 5/2021

Immunologic Research 5/2021 Go to the issue